Key result
Viral infections, including cytomegalovirus and human herpesvirus 6, are discussed as potential triggers for cardiac-allograft dysfunction.
Why the study?
Do viral infections such as cytomegalovirus and human herpesvirus 6 contribute to cardiac-allograft dysfunction in transplant recipients?
Do viral infections such as cytomegalovirus and human herpesvirus 6 contribute to cardiac-allograft dysfunction in transplant recipients?
Answers are grounded in this paper and cite their sources.
This editorial discusses the emerging evidence and ongoing debate regarding the role of viral infections, including CMV and HHV-6, in triggering cardiac-allograft dysfunction and vasculopathy.
The question of a viral contribution to allograft dysfunction after solid-organ transplantation has long been debated. This debate has focused primarily on cytomegalovirus, which has been identified as a risk factor for bronchiolitis obliterans in lung-transplant recipients1 and may be associated with a variety of forms of chronic allograft dysfunction in other solid-organ transplants. There is considerable evidence, but still some controversy, concerning the role of cytomegalovirus in cardiac-allograft vasculopathy, one of the primary conditions limiting survival in cardiac-transplant recipients.2 Recent reports have raised the possibility that human herpesvirus 6 (HHV-6) infection may also be associated with allograft dysfunction.3 In . . .
No takes yet. Share an insight, caveat, or question.
Robin K. Avery (2001) conducted an editorial in Cardiac-allograft dysfunction. Viral infection (cytomegalovirus, HHV-6) was evaluated. Viral infections, including cytomegalovirus and human herpesvirus 6, are discussed as potential triggers for cardiac-allograft dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: